Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

INSAPANT

Financiado

Innovative tools to use south African plant extract in advanced delivery systems...

Innovative tools to use south African plant extract in advanced delivery systems for antibacterial applications Multidrug-resistant bacteria are becoming implicated more frequently in acute and chronic infections. Bacteria often live together in a biofilm community, which makes it easier for bacteria to become resistant to different classes... ver más

07/01/2026

Ud'A

189K€

Presupuesto del proyecto: 189K€

Líder del proyecto

UNIVERSITA DEGLI STUDI GABRIELE DANNUNZIO DI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-28

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

2 Participantes

Ud'A

188.59K€ | Lider

UNINA

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

SUPREME Polymeric Cyclodextrin-Based Supramolecular Constructs Photo... 173K€ Cerrado

RTI2018-099019-A-I00 DESARROLLO DE TECNOLOGIAS DE FLUJO CONTINUO BASADAS EN SISTE... 128K€ Cerrado

PID2020-114347RB-C31 DISEÑO Y SINTESIS DE NANOPARTICULAS MOLECULARES Y BIOMOLECUL... 133K€ Cerrado

PCI2022-132923 NANO-ENABLED STIMULI-RESPONSIVE SCAFFOLDS FOR TARGETED ANTIM... 250K€ Cerrado

PLEC2022-009356 Nanoterapía disruptiva para combatir AMR por desagregación d... 273K€ Cerrado

TED2021-132122B-C22 DISEÑO Y SINTESIS DE NANODISPOSITIVOS BIOMOLECULARES SOSTENI... 151K€ Cerrado

Duración del proyecto: 25 meses Fecha Inicio: 2023-11-28
Fecha Fin: 2026-01-07

Líder del proyecto

UNIVERSITA DEGLI STUDI GABRIELE DANNUNZIO DI... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 189K€

Descripción del proyecto Multidrug-resistant bacteria are becoming implicated more frequently in acute and chronic infections. Bacteria often live together in a biofilm community, which makes it easier for bacteria to become resistant to different classes of antibiotics. This poses a severe threat to global public health, and the fact that antibiotics have many side effects makes the situation even worse. It is imperative to search for novel, safe, and effective antimicrobial agents and robust drug delivery strategies. In INSAPANT, South African plants will be employed for the green synthesis of biogenic nanoparticles, and their antibacterial potential against biofilm associated with multidrug-resistant bacteria will be investigated. The main goal of the INSAPANT is to exploit a synergic therapeutic approach by designing a novel delivery system targeted with aptamers that will carry the biogenic nanoparticles selectively on site of action and protect them following systemic administration. This combinatorial strategy can potentially remove the biofilm in a manner that is more efficient than a passive release or the administration of the content alone. INSAPANT has significant social benefits since it has the potential to lead to the creation of a unique drug delivery system for the treatment of biofilm formation and, ultimately, the reduction of mortality caused by bacterial infections. The INSAPANT fellowship will contribute to i) Expose the researcher to a multidisciplinary and intersectoral research network and foster excellence in research; ii) Improve the researcher's project management and fundraising skills; iii) Enhance the researcher's communication, dissemination, and exploitation of results, as well as Transfer of Knowledge to various audiences; and iv) Boost the researcher's career development skills.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores